Risk factor
Negligible price volatility
Profitability factor
Weak growth
About
Dr. Soliman Abdel Kader Fakeeh Hospital Company establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, breast feeding clinic, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pain treatment service, palliative care services, pediatric department, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery. The company also operates AIRS, NICU, endoscopy, the institute of robotic surgery, anesthesia, emergency medicine, intensive care, renal dialysis, rhinoplasty center, and burn units; establishes and manages pharmacies; and laboratory services. In addition, it engages in the wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was founded in 1978 and is headquartered in Jeddah, the Kingdom of Saudi Arabia.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of 4017.SR is 42 and suggests 16% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
